ANNOUNCEMENT {#s1}
============

Bacillus anthracis is a spore-forming, Gram-positive bacterium that causes anthrax disease. Natural resistance to the two commonly used postexposure prophylactic antibiotics, doxycycline (DOX) and ciprofloxacin (CIP), is rare. To understand the mechanism of ciprofloxacin resistance, mutants of an attenuated Bacillus anthracis strain with high-level CIP resistance (\>32 μg/ml) were isolated using a three-step *in vitro* selection protocol ([@B1]). Step 1 mutants were resistant to 0.5 μg/ml of CIP and had one of two *gyrA* quinolone resistance-determining region (QRDR) mutations. Step 2 mutants, derived from step 1 isolates, were resistant to 8 to 16 μg/ml of CIP and had one of three *parC* QRDR mutations. Step 3 mutants, derived from step 2 isolates, were resistant to 32 to 64 μg/ml of CIP. Mutants with an MIC of 64 μg/ml had one of two additional mutations within the *gyrA* QRDR or one of two mutations within the *gyrB* QRDR. Mutants for which the MIC was 32 μg/ml had no additional target modiﬁcations but showed evidence of enhanced ciproﬂoxacin efﬂux. Indeed, mutations in a TetR-type transcriptional regulator upstream of a gene encoding an efflux pump protein were shown to be present in some of these mutants ([@B2]). To establish the link between the high-level CIP resistance phenotype and the unknown non-QRDR genetic changes, we sequenced the genomes of these mutants. Here, we report the whole-genome sequences of the parent and its derivatives.

For DNA preparation, all strains were plated from glycerol stocks onto tryptic soy agar plates and incubated overnight at 37°C. One colony was transferred to 15 ml of tryptic soy broth and grown overnight at 37°C with shaking at 250 rpm. The culture tube was centrifuged, and the pellet was used for DNA extraction using the Epicentre MasterPure Gram-positive DNA purification kit (catalog no. MGP04100) according to the manufacturer's instructions. DNA samples were quantified using the Invitrogen Quant-iT PicoGreen double-stranded DNA (dsDNA) kit and a Lambda DNA standard. The concentration and purity of 2-μl DNA samples were determined from absorption ratios at both 260/280 and 230/260 nm using the NanoDrop 2000 instrument.

Sequencing libraries were prepared using the Illumina Nextera XT kit and sequenced on an Illumina MiSeq (v2 mid-output 2 × 151-bp) instrument. MiSeq quality filters were used on quality-controlled (QC) reads, and the average Phred score was Q30. Adapter sequences were removed with Cutadapt ([@B3]) and assembled using Velvet v1.2.10 ([@B4]). The genome was annotated with the NCBI Prokaryotic Genome Annotation Pipeline v4.10 ([@B5]), and reference mapping was done with Bowtie 2 v2.3.5.1 ([@B6]). Default parameters were used for all software with the exception of Velvet (k-mer size, 2/3 of the average read length after adapter removal; -exp_cov auto) and Bowtie (-n-ceil "0.0.30"; --very-sensitive-local).

Data availability. {#s1.1}
------------------

The accession numbers and sequence statistics of the 20 genomes are listed in [Table 1](#tab1){ref-type="table"}.

###### 

Genome sequence details of B. anthracis ΔANR and its CIP-resistant derivatives[^*a*^](#ngtab1.1){ref-type="table-fn"}

  Strain   UCC no.[^*b*^](#ngtab1.2){ref-type="table-fn"}   CIP^r^ level[^*c*^](#ngtab1.3){ref-type="table-fn"}   SRA accession no.                                             GenBank accession no.                                               Total no. of reads   Assembly size (bp)   No. of contigs   No. of CDSs[^*d*^](#ngtab1.4){ref-type="table-fn"}   Depth of coverage[^*e*^](#ngtab1.5){ref-type="table-fn"} (×)   Breadth of coverage[^*f*^](#ngtab1.6){ref-type="table-fn"} (%)
  -------- ------------------------------------------------ ----------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------- -------------------- -------------------- ---------------- ---------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------------------
  ΔANR     BACI355                                          Sen                                                   [SRR10820631](https://www.ncbi.nlm.nih.gov/sra/SRR10820631)   [WUDB00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUDB00000000)   7,704,385            5,180,208            103              5,329                                                210                                                            99.93
  S1-1     BACI356                                          I                                                     [SRR10820630](https://www.ncbi.nlm.nih.gov/sra/SRR10820630)   [WXXJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXJ00000000)   5,935,864            5,114,359            56               5,271                                                167                                                            99.93
  S1-2     BACI357                                          I                                                     [SRR10820619](https://www.ncbi.nlm.nih.gov/sra/SRR10820619)   [WXXI00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXI00000000)   7,674,652            5,442,523            67               5,566                                                206                                                            99.93
  S2-1     BACI358                                          II                                                    [SRR10820618](https://www.ncbi.nlm.nih.gov/sra/SRR10820618)   [WXXH00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXH00000000)   12,594,028           4,990,635            286              5,180                                                352                                                            99.93
  S2-2     BACI359                                          II                                                    [SRR10820617](https://www.ncbi.nlm.nih.gov/sra/SRR10820617)   [WXXG00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXG00000000)   10,599,687           5,048,612            191              5,206                                                292                                                            99.93
  S2-3     BACI360                                          II                                                    [SRR10820616](https://www.ncbi.nlm.nih.gov/sra/SRR10820616)   [WXXF00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXF00000000)   9,362,926            4,962,434            279              5,177                                                230                                                            99.93
  S3-1     BACI361                                          III                                                   [SRR10820615](https://www.ncbi.nlm.nih.gov/sra/SRR10820615)   [WUDA00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUDA00000000)   10,556,085           4,901,717            252              5,117                                                216                                                            98.01
  S3-3     BACI362                                          III                                                   [SRR10820614](https://www.ncbi.nlm.nih.gov/sra/SRR10820614)   [WUCZ00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCZ00000000)   8,594,796            5,187,801            34               5,293                                                240                                                            99.93
  S3-4     BACI363                                          III                                                   [SRR10820613](https://www.ncbi.nlm.nih.gov/sra/SRR10820613)   [WXXE00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXE00000000)   8,252,056            4,867,450            230              5,036                                                232                                                            99.93
  S3-5     BACI364                                          III                                                   [SRR10820612](https://www.ncbi.nlm.nih.gov/sra/SRR10820612)   [WXXD00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXD00000000)   11,159,148           5,110,766            173              5,261                                                287                                                            99.93
  S3-6     BACI365                                          III                                                   [SRR10820629](https://www.ncbi.nlm.nih.gov/sra/SRR10820629)   [WXXC00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXC00000000)   8,698,057            4,942,892            59               5,064                                                221                                                            99.93
  S3-7     BACI366                                          III                                                   [SRR10820628](https://www.ncbi.nlm.nih.gov/sra/SRR10820628)   [WUCY00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCY00000000)   10,373,919           5,732,249            53               5,834                                                287                                                            99.90
  S3-8     BACI367                                          III                                                   [SRR10820627](https://www.ncbi.nlm.nih.gov/sra/SRR10820627)   [WUCX00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCX00000000)   10,340,752           5,003,507            98               5,128                                                289                                                            99.93
  S3-11    BACI368                                          III                                                   [SRR10820626](https://www.ncbi.nlm.nih.gov/sra/SRR10820626)   [WXXB00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXB00000000)   7,704,786            5,064,510            39               5,164                                                215                                                            99.93
  S3-12    BACI369                                          III                                                   [SRR10820625](https://www.ncbi.nlm.nih.gov/sra/SRR10820625)   [WXXA00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXXA00000000)   8,613,155            5,179,602            46               5,275                                                243                                                            99.93
  S3-14    BACI370                                          III                                                   [SRR10820624](https://www.ncbi.nlm.nih.gov/sra/SRR10820624)   [WUCW00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCW00000000)   6,026,125            5,070,985            33               5,182                                                169                                                            99.93
  S3-15    BACI371                                          III                                                   [SRR10820623](https://www.ncbi.nlm.nih.gov/sra/SRR10820623)   [WUCV00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCV00000000)   7,543,074            5,185,778            29               5,295                                                202                                                            99.93
  S3-16    BACI372                                          III                                                   [SRR10820622](https://www.ncbi.nlm.nih.gov/sra/SRR10820622)   [WXWZ00000000](https://www.ncbi.nlm.nih.gov/nuccore/WXWZ00000000)   8,911,392            5,422,954            43               5,570                                                240                                                            99.93
  S3-17    BACI373                                          III                                                   [SRR10820621](https://www.ncbi.nlm.nih.gov/sra/SRR10820621)   [WUCU00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCU00000000)   7,496,750            5,239,352            30               5,335                                                211                                                            99.93
  S3-18    BACI374                                          III                                                   [SRR10820620](https://www.ncbi.nlm.nih.gov/sra/SRR10820620)   [WUCT00000000](https://www.ncbi.nlm.nih.gov/nuccore/WUCT00000000)   8,075,762            5,330,389            41               5,437                                                223                                                            99.93

![](MRA.00056-20-t0001)

The differences in the genome sizes and gene numbers between the parent and derivatives could be due to the fact that these are draft and unfinished sequences with multiple contigs, as opposed to a single closed contig, and hence may have potential gaps in the assembly.

UCC, Unified Culture Collection of the U.S. Army Medical Research Institute of Infectious Diseases (<https://www.usamriid.army.mil/ucc/>).

CIP^r^, ciprofloxacin resistance; Sen, sensitive at 0.06 μg/ml. Resistance levels, I, 0.5 μg/ml; II, 8 to 16 μg/ml; and III, 32 to 64 μg/ml.

CDSs, coding sequences.

Reference sequence accession no. [NZ_CP008752](https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP008752).

Against the reference sequence.
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